Camp4 Therapeutics Corporation (CAMP)

NASDAQ: CAMP · Real-Time Price · USD

1.495

-0.045 (-2.92%)

Jul 11, 2025, 2:03 PM - Market open

Camp4 Therapeutics Employees

Camp4 Therapeutics had 55 employees as of December 31, 2024. The number of employees decreased by 9 or -14.06% compared to the previous year.

Employees

55

Change (1Y)

-9

Growth (1Y)

-14.06%

Revenue / Employee

$27,455

Profits / Employee

-$941,309

Market Cap

30.13M

Employees Chart

Employees History

Date	Employees	Change	Growth
Dec 31, 2024	55	-9	-14.06%
Dec 31, 2023	64	-	-

Related Stocks

Company Name	Employees
UnitedHealth Group	400,000
Johnson & Johnson	138,100
Thermo Fisher Scientific	125,000
Abbott Laboratories	114,000
AstraZeneca	94,300
Novo Nordisk	77,349
Novartis AG	75,883
Merck & Co.	75,000

Employee Rankings

CAMP News

2 months ago - CAMP4 Presents Translational Data from SYNGAP1-Related Disorders Program Showcasing Increased Protein in Non-Human Primates and Reviews Preclinical and Detailed Single Ascending Dose Safety Data from Urea Cycle Disorders Program at the 28th American Society of Gene and Cell Therapy Annual Meeting - GlobeNewsWire
2 months ago - CAMP4 Reports First Quarter 2025 Financial Results and Corporate Highlights - GlobeNewsWire
2 months ago - CAMP4 to Present New Preclinical Data from its Urea Cycle Disorders and SYNGAP1-Related Disorders Programs at the 28th American Society of Gene and Cell Therapy Annual Meeting - GlobeNewsWire
3 months ago - Top 3 Health Care Stocks That Could Lead To Your Biggest Gains In Q2 - Benzinga
3 months ago - CAMP4 Reports Full Year 2024 Financial Results and Provides Corporate Update - GlobeNewsWire
4 months ago - CAMP4 Appoints Multiple Industry Veterans to its Board of Directors - GlobeNewsWire
4 months ago - CORRECTION - CalAmp Synovia to Showcase Leading Student Transportation Solutions at STN East 2025 - GlobeNewsWire
4 months ago - CalAmp Synovia to Showcase Leading Student Transportation Solutions at STN East 2025 - GlobeNewsWire